Exact Sciences Soars on $2.15 Billion Deal for Testing Firm

(Bloomberg) — Exact Sciences Corp. said it will acquire Thrive Earlier Detection Corp. to gain technology for cancer screening in a deal worth as much as $2.15 billion.The cash and stock agreement will bring closely held Thrive’s CancerSeek technology to Exact Sciences, helping establish the Madison, Wisconsin-based company as a competitor in blood-based, multi-cancer screening, according to a statement. Exact Sciences jumped as much as 22% to $130, its highest since the shares began trading in 2001.Testing companies are increasingly developing liquid biopsies that sift through patients’ blood for early signs of tumors, hoping to help doctors begin treatment before …read more

Source:: Yahoo Finance


Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.